Kronox Lab Sciences Ltd IPO
Open Demat Account
Kronox Lab Sciences Ltd IPO Details
Details
| Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
|---|---|---|---|---|---|
| 95.7 L | 95.7 L | 33.5 L | 370.94 L | BSE | ₹ 130.15 Cr |
| IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
| 03 Jun, 24 | 05 Jun, 24 | 110 | ₹ 14,190 | Book Building | 10 Jun, 24 |
Kronox Lab Sciences Ltd IPO Dates
Details
| Sector | Type |
|---|---|
| Sector | Chemicals |
| Sub Sector | NA |
| Issue Type | Book Building |
Subscription Status
*Values are in Lakhs
| Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
|---|---|---|---|
| QIB | 35.61x | 4785000 | 170409360 |
| NII | 302.99x | 1435500 | 434939340 |
| Retail | 55.72x | 3349500 | 186633920 |
| Employee | 0x | 0 | 0 |
| Total | 82.76x | 9570000 | 791982620 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Kronox Lab Sciences Ltd Financial Status
Income Statement
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 23.82 | 20.38 | 15.20 |
| EBITDA | 25.32 | 22.41 | 17.18 |
| PAT | 16.62 | 13.63 | 9.73 |
| Total Assets | 34.52 | 44.49 | 26.46 |
| Share Capital | 37.10 | 0.24 | 0.24 |
| Total Borrowings | 3.24 | 8.54 | 3.48 |
| Operating Activities (Net Cash) | 18.12 | 15.66 | 11.71 |
| Investing Activities (Net Cash) | 0.03 | 0.03 | -0.37 |
| Financing Activities (Net Cash) | 3.24 | 8.54 | 3.48 |
| Net Cashflow | 3.56 | 2.81 | 2.05 |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Kronox Lab Sciences Ltd
Kronox Lab Sciences Limited was incorporated on November 18, 2008 as `Kronox Lab Sciences Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2008 issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted into a public limited company pursuant to a resolution passed by its shareholders at an extra-ordinary general meeting held on May 25, 2019 and a fresh certificate of incorporation dated June 11, 2019 was issued by the Registrar of Companies, Ahmedabad consequent upon conversion, recording the change in the name of the Company to `Kronox Lab Sciences Limited'.
The chemical industry is an integral element of the global economy and plays a critical role in nearly every facet of modern life serving numerous sectors such as agriculture, construction, automotive, FMCG, consumer durables, electronics, healthcare, etc. The global chemical industry is continually evolving through technological advancements, market dynamics, and sustainability initiatives. The size of the Indian chemicals industry, excluding pharmaceuticals, in terms of the value of output in the year FY22 was around Rs. 9.10 lakh crores and 8.4% of the value of the output of the manufacturing sector at constant prices as against 7.9% in FY18. The chemical and chemical products except pharmaceuticals has registered a CAGR of 8.8% from FY18 to FY22. Furthermore, as per the Government of India's Department of Chemicals and Petrochemicals, India ranks 11th in the world exports of chemicals (excluding pharmaceutical products) and 6th in the world imports of chemicals (excluding pharmaceutical products).
Peer Comparison:
- No Listed Industry Peers
Kronox Lab Sciences Ltd IPO Key Points
Strengths
- Wide range of products finding applications in diversified end user industries.
- Long standing relationships with customers.
- High entry and exit barriers due to long customer approval cycles and strict product standards.
- Focus on R&D and Quality Control.
- Zero debt company with strong and consistent financial performance.
Risk
- The company's products are required to meet domestic and international industry standards. In the event of any deviation from these standards, its products may faces rejection from its customers, which may affect the reputation of the Company.
- If the company fails to execute its strategy to expand its business or the company's production capacity, its business and prospects may be materially and adversely affected.
- Its products are supplied in limited quantities for specific use by application industries. Any reduction in the requirement of its products may result in loss of business and may affect its financial performance and condition.
Strategy
- Expand its product portfolio, increasing the supply of its products to its existing customers and tap new customers in existing and new geographies.
- Expand its capacity for existing products and diversifying into new products by setting up a new manufacturing facility.
- Explore newer applications for its existing products and developing new products that are in synergy with its current and future operations.
- Focus on import substitution and increasing exports.
- Improve cost management and operational efficiencies.
- Wide range of products finding applications in diversified end user industries.
- Long standing relationships with customers.
- High entry and exit barriers due to long customer approval cycles and strict product standards.
- Focus on R&D and Quality Control.
- Zero debt company with strong and consistent financial performance.
How To Apply for Kronox Lab Sciences Ltd Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.
